Simmunome AI

Simmunome offers a cutting-edge platform that utilizes mechanistic modeling combined with machine learning to simulate the efficacy and safety of drug targets, reducing late-stage failures.

Health and bio EducationPlug and PlayGoogle for Startups Accelerator

Website: simmunome.com.

Categories: Health and bio Education.

Sectors: Health & Longevity.

Based in: Montréal, Canada.

On Recent Funding since: Sep 28, 2026.

Signals

Website registeredSep 16, 2016 (10 years old)

Timeline

Alberta Health Batch 5
PPlug and Play · batch
Source: public.dxp.playbook.vc
September 16, 2016
Website created
Canada
GGoogle for Startups Accelerator · batch
Source: startup.google.com

Investors

Companies like Simmunome AI

OOpenEyes$18M Series A · Feb 2023
EEpilepsy GTx$33M Series A · Dec 2025
JJustt$30M Series B+ · Dec 2024
BBaseten$1.5B Series B+ · Jun 2026
SSingleCell BiotechnologyPre Seed
SSIGN3 TechnologiesSeed · Mar 2026

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/simmunome-ai (get a free API key).